Question 1

Am I eligible for this trial based on my specific cancer mutation?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the drugs being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

Question 4

What will my treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if my cancer worsens while I am in the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations clinical trial (NCT06517953). Contact the study team or your healthcare provider for specific answers.

What this study is about